ArticleJournal of translational medicine2020

An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy.

Jinglei Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.